Bone and cancer: the osteoncology (Q38153390)

29 August 2017

Bone and cancer: the osteoncology (English)

1 reference

29 August 2017

Toni Ibrahim

1

1 reference

29 August 2017

Laura Mercatali

series ordinal

2

1 reference

29 August 2017

Dino Amadori

series ordinal

3

1 reference

29 August 2017

1 May 2013

1 reference

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

121-123

1 reference

29 August 2017

2

1 reference

Metastatic bone disease in the era of bone-targeted therapy: clinical impact

29 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Antiresorptive therapies in oncology and their effects on cancer progression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Pathogenesis of osteoblastic bone metastases from prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Risks and benefits of bisphosphonates

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Orthopedic surgery options for the treatment of primary osteosarcoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

[Malignant tumours of the locomotor apparatus in children: an "intermediate" prognosis].

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

6 September 2017

Tumor metastasis to bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Clinical course and prognostic factors following bone recurrence from breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational model.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3796999

Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer Patients

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24133529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24133529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24133529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

29 August 2017

1 reference